Suppr超能文献

疫苗犹豫——对非洲疫苗接种规划成果的潜在威胁。

Vaccine hesitancy - a potential threat to the achievements of vaccination programmes in Africa.

机构信息

a Cochrane South Africa, South African Medical Research Council , Parow Valley, Cape Town , South Africa.

b School of Public Health and Family Medicine, University of Cape Town , Cape Town , South Africa.

出版信息

Hum Vaccin Immunother. 2018;14(10):2355-2357. doi: 10.1080/21645515.2018.1460987. Epub 2018 May 22.

Abstract

Vaccination programmes in Africa have made extraordinary progress over the last four decades. Yet, vaccine hesitancy threatens to erode these gains. Vaccine hesitancy is a continuum between vaccine acceptance and refusal. A growing number of people in Africa are delaying or refusing recommended vaccines for themselves or their children, even when safe and effective vaccines are available. This predisposes communities to infectious diseases, resulting in multiple disease outbreaks, ultimately consuming resources and costing lives. Vaccine hesitancy is currently receiving unprecedented global attention, however, there remains several knowledge gaps, particularly in Africa. The vast majority of research on this topic has been conducted in high income countries. Little is therefore known about the nature and causes of vaccine hesitancy in Africa, and evidence-based interventions in the region to address it are also limited. Moreover, tools to measure vaccine hesitancy are scarce, and none that exist have been validated in Africa. We discuss these knowledge gaps, and propose a research and capacity building agenda to better measure and overcome vaccine hesitancy in Africa. Ultimately, this is essential if we hope to enhance and sustain public demand for vaccination and preserve the tremendous achievements of vaccination programmes on the continent.

摘要

在过去的四十年里,非洲的疫苗接种计划取得了非凡的进展。然而,疫苗犹豫正威胁着这些成果的侵蚀。疫苗犹豫是在疫苗接受和拒绝之间的一个连续体。越来越多的非洲人开始拖延或拒绝为自己或孩子接种推荐的疫苗,即使有安全有效的疫苗可用。这使社区容易受到传染病的影响,导致多次疾病爆发,最终消耗资源并导致生命损失。疫苗犹豫目前正在受到前所未有的全球关注,但仍存在一些知识空白,特别是在非洲。关于这个话题的绝大多数研究都是在高收入国家进行的。因此,对于非洲疫苗犹豫的性质和原因知之甚少,并且在该地区解决这一问题的循证干预措施也很有限。此外,衡量疫苗犹豫的工具稀缺,并且现有的工具都没有在非洲得到验证。我们讨论了这些知识空白,并提出了一个研究和能力建设议程,以更好地衡量和克服非洲的疫苗犹豫。如果我们希望增强和维持公众对疫苗接种的需求,并维护非洲大陆疫苗接种计划取得的巨大成就,这是至关重要的。

相似文献

3
Strategies implemented to address vaccine hesitancy in France: A review article.法国应对疫苗犹豫的策略:一篇综述文章。
Hum Vaccin Immunother. 2018 Jul 3;14(7):1580-1590. doi: 10.1080/21645515.2018.1458807. Epub 2018 Jun 14.

引用本文的文献

本文引用的文献

1
2
Measuring vaccine hesitancy: The development of a survey tool.衡量疫苗犹豫程度:一种调查工具的开发
Vaccine. 2015 Aug 14;33(34):4165-75. doi: 10.1016/j.vaccine.2015.04.037. Epub 2015 Apr 18.
3
Vaccine hesitancy: Definition, scope and determinants.疫苗犹豫:定义、范围及决定因素
Vaccine. 2015 Aug 14;33(34):4161-4. doi: 10.1016/j.vaccine.2015.04.036. Epub 2015 Apr 17.
4
Strategies for addressing vaccine hesitancy - A systematic review.应对疫苗犹豫的策略——一项系统综述
Vaccine. 2015 Aug 14;33(34):4180-90. doi: 10.1016/j.vaccine.2015.04.040. Epub 2015 Apr 18.
10
Vaccine hesitancy: an overview.疫苗犹豫:概述。
Hum Vaccin Immunother. 2013 Aug;9(8):1763-73. doi: 10.4161/hv.24657. Epub 2013 Apr 12.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验